Aditya Bagrodia is an Assistant Professor in the Department of Urology at UT Southwestern Medical Center, where he is the Dedman Family Scholar in Clinical Care. 

Dr. Bagrodia holds a bachelor of science degree from Rhodes College. While earning a medical degree with highest honors at the University of Tennessee Health Sciences Center, he was awarded a Doris Duke Clinical Research Fellowship in clinical research at UT Southwestern Medical Center.

After graduating from residency in urology at UT Southwestern, he completed a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center, where he received an American Urological Association Urology Care Foundation Research Scholars Grant.

Dr. Bagrodia’s clinical and research focus centers on patients with germ cell tumors.  His laboratory focuses on sequencing efforts to understand tumor evolution and heterogeneity in germ cell tumors as well as to identify novel biomarkers to recognize occult metastatic disease.  The Bagrodia lab also conducts experiments in cell lines and zebrafish germ cell tumor models to understand the biologic implications of genetic alterations that are seen exclusively among patients with cisplatin-resistance disease.  On the clinical side, Dr Bagrodia is actively involved with understanding and overcoming unique socioepidemiologic considerations that adversely impact oncologic outcomes in patients with germ cell tumors.  He is also the prinicipal investigator for several germ cell tumor-directed clinical trials at UT Southwestern (NCT03426865, NCT02537548).

Dr. Bagrodia has conducted extensive research in urologic oncology, primarily in biomarker profiles and molecular signatures of urologic tumors as predictors of clinical outcomes. He has also been an investigator in studies that compare the efficacy of surgical techniques, analyze the influence of pre-existing clinical conditions on surgical outcomes, and evaluate the use of radiotherapy and chemotherapy in conjunction with surgical treatment of urologic cancers.

He is the principal author or co-author of more than 90 articles in peer-reviewed publications such as Journal of Clinical Oncology, Nature Genetics, European Urology, Journal of Urology, Urologic Oncology, and Urology. He is also a reviewer for many of these publications, as well as the British Journal of Urology, the Journal of Clinical Pathology, and Annals of Surgical Oncology.